Craniopharyngioma diagnostic study of choice

Jump to navigation Jump to search

Craniopharyngioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Craniopharyngioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Craniopharyngioma diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Craniopharyngioma diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Craniopharyngioma diagnostic study of choice

CDC on Craniopharyngioma diagnostic study of choice

Craniopharyngioma diagnostic study of choice in the news

Blogs on Craniopharyngioma diagnostic study of choice

Directions to Hospitals Treating Craniopharyngioma

Risk calculators and risk factors for Craniopharyngioma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

The diagnostic evaluation of craniopharyngioma includes high-definition brain imaging. Brain MRI with and without contrast is the gold standard. Computed tomography (CT) scan is optional and may show some calcifications that can be seen in these tumors. However CT is not specific enough as a standalone diagnostic test. vascular imaging studies such as MR angiography (MRA) or CTA, is decided on a case-by-case basis typically for surgical planning or if a possible vascular malformation is spuspected.

Diagnostic Study of Choice

  • Craniopharyngiomas have the most heterogeneous radiologic appearance of any suprasellar neoplasm.
  • Craniopharyngioma can offer a challenge in arriving at the correct diagnosis. In particular, the radiologic characteristics of Rathke cleft cyst can overlap that of adamantinomatous craniopharyngioma.

Study of choice

  • Pre and post contrast enhanced MR imaging with attention to the sellar region is the modality of choice when evaluating craniopharyngioma.
  • The superior contrast resolution and tissue characterization, as well as the multiplanar capability of this technique, make it the radiologist’s most indispensable tool.
  • High-resolution, thin-section, T1-weighted imaging of the sellar region in the sagittal and coronal planes is mandatory, and should be obtained both pre- and post-contrast administration.
  • Dynamic enhanced imaging of the sellar region can be performed if diagnostic considerations include pituitary microadenoma or the rare parasellar cavernous hemangioma.
  • CT is also sensitive in the detection of fat density, which is valuable in the suprasellar region when the differential include Rathke cleft cyst.

References

Template:WH Template:WS